RAB27B and chronic myelogenous leukemia, BCR-ABL1 positive: Knocking down RAB27B expression inhibited the proliferation and imatinib resistance of CML cells, and promoted CML cell apoptosis, suggesting that RAB27B promotes the development and/or progression of CML.